Growing public fascination with "magic" psilocybin mushrooms as a trendy treatment for depression had led to increased ...
When David Christie paid a visit to his son and daughter-in-law in Sussex two years ago, he had a far more exciting trip than usual. The 78-year-old had begun to suffer from periods of low mood.
The active ingredient in magic mushrooms is a particularly effective treatment for symptoms of depression in older patients, according to a study. Scientists at the University of Oxford analysed ...
A Health Canada-approved clinical trial is seeking 20 local participants who have been diagnosed with post-traumatic stress ...
A WOMAN appears to have cured herself of long Covid by taking psychedelic drugs. The 41-year-old was struggling with severe ...
Taking silly selfies with a beloved friend, laughing as we posed for the camera, my eyes sparkling, my smile bright, I felt a ...
There has been a resurgence of interest in the use of psychedelics or consciousness altering substances such as psilocybin – the active ingredient in “magic mushrooms” to treat depression.
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.
In an intriguing development, researchers are exploring the potential of psychedelics as a treatment for long Covid symptoms.
Like the more famous psilocybin mushrooms, Amanita muscaria mushrooms have psychotropic effects, including a feeling of ...
During a psychotherapy session, one of my patients reported to me that the antidepressants he'd been prescribed by his GP had ...